Walgreen
Executive Summary
Senior VP and Treasurer Daniel Jorndt, 48, named president and chief operating officer. He succeeds Fred Canning, 65, who is retiring Feb. 1. Charles Hunter, exec VP, is named vice chairman and will continue as chief financial officer. Firm announces Oct. 11 that fiscal 1989 prescription revenues rose 20% to $1.6 bil. Pharmacy operations made up 30% of overall sales, which were $5.4 mil. Firm opened 89 new stores in fiscal 1989 (ended Aug. 31) and renovated 157 stores, including 99 pharmacies. Plans call for 180 remodelings in fiscal 1990.
You may also be interested in...
Biden Administration Is Setting An Example For Safe AI Use In Federal Organizations
A new memorandum by the Director of the Office of Management and Budget initiated a government-wide policy that will appoint AI officers to all agencies to address risks for AI use and serve as an example for greater AI adoption.
US FDA Drugs Center Ready To Break Down Silos On Regulatory Innovation
CDER Director Cavazzoni is promising to increase coordination and collaboration to accelerate broader adoption of innovative clinical trial designs and other approaches to speed drug development. A new "Quantitative Medicine Center of Excellence" illustrates the approach.
New OSP Director To Guide CDER-Wide IT Upgrades; System Enhancements Speed ANDA Assessments
Generic Drug Structured Assessment for Bioequivalence launched in 2023 and has been used in 40 ANDA reviews so far.